# Thrombolysis Endovascular Treatment of Pulmonary Embolism

> **NCT03966079** · PHASE3 · COMPLETED · sponsor: **Beijing Tsinghua Chang Gung Hospital** · enrollment: 50 (actual)

## Conditions studied

- Pulmonary Embolism
- Acute Pulmonary Embolism

## Interventions

- **DRUG:** recombinant tissue plasminogen activator

## Key facts

- **NCT ID:** NCT03966079
- **Lead sponsor:** Beijing Tsinghua Chang Gung Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03966079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03966079, "Thrombolysis Endovascular Treatment of Pulmonary Embolism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03966079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*